AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RIFABUTIN
3 registrations across 3 African markets— 2 active
Markets with RIFABUTIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Mycobutin Capsules 150 mg** Capsule | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Nov 2025 |
| MYCOBUTIN 150MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2024 |
| MYCOBUTIN | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
RIFABUTIN in Africa — Regulatory Overview
RIFABUTIN is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 2 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.